Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander A Morley

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Leukemia & Lymphoma|December 1, 2016
Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCRIvar O Kommers, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|April 17, 2022
Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCRSue Latham, Elizabeth Hughes, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemiaAlexander A Morley, Sue Latham, Michael J Brisco, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemiaMichael J Brisco, Sue Latham, Rosemary Sutton, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Leukemia & Lymphoma|December 1, 2016
Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCRIvar O Kommers, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|April 17, 2022
Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCRSue Latham, Elizabeth Hughes, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemiaAlexander A Morley, Sue Latham, Michael J Brisco, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemiaMichael J Brisco, Sue Latham, Rosemary Sutton, et al.
Pageof 3